Lanean...

Genetic dissection of histone deacetylase requirement in tumor cells

Histone deacetylase inhibitors (HDACi) represent a new group of drugs currently being tested in a wide variety of clinical applications. They are especially effective in preclinical models of cancer where they show antiproliferative action in many different types of cancer cells. Recently, the first...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Haberland, Michael, Johnson, Aaron, Mokalled, Mayssa H., Montgomery, Rusty L., Olson, Eric N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2009
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2683118/
https://ncbi.nlm.nih.gov/pubmed/19416910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0903139106
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!